J, C., & NL, F. (2025). Active targeting of type 1 diabetes therapies to pancreatic beta cells using nanocarriers. Diabetologia, 68(4), 692. https://doi.org/10.1007/s00125-024-06356-5
Chicago Style (17th ed.) CitationJ, Collins, and Farnsworth NL. "Active Targeting of Type 1 Diabetes Therapies to Pancreatic Beta Cells Using Nanocarriers." Diabetologia 68, no. 4 (2025): 692. https://doi.org/10.1007/s00125-024-06356-5.
MLA (9th ed.) CitationJ, Collins, and Farnsworth NL. "Active Targeting of Type 1 Diabetes Therapies to Pancreatic Beta Cells Using Nanocarriers." Diabetologia, vol. 68, no. 4, 2025, p. 692, https://doi.org/10.1007/s00125-024-06356-5.
Warning: These citations may not always be 100% accurate.